MedPath

Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue

Not Applicable
Terminated
Conditions
Cervix
Cancer
Registration Number
NCT00250055
Lead Sponsor
University of New Mexico
Brief Summary

In general, to determine the sensitivity of light transport to tissue from morphological features of clinical significance.

Determine how specific structural features contribute to light scattering. Investigate light scattering differences in tumorigenic and nontumorigenic cells.

Develop and implement quantitative and sensitive methods for measuring morphological properties.

Clinical measurements.

Detailed Description

Patients undergoing a colposcopy will also have spectroscopy measurements taken and an extra biopsy of suspicious tissue.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Patients with abnormal Pap smears who are referred for colposcopy.

Exclusion criteria include:

  • Anyone of the male sex since this study focuses on cervical cell abnormalities
  • Any woman who has had a hysterectomy, LEEP, or chemotherapy.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
The objective of this study is to determine whether non-invasive measurements of light transport through tissue can identify pre-cancerous and cancerous conditions.6 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of New Mexico

🇺🇸

Albuquerque, New Mexico, United States

© Copyright 2025. All Rights Reserved by MedPath